化学剥脱术中高浓度果酸类产品的临床应用及监管路径探究  

Clinical Application and Regulatory Pathway Discussion on Alpha Hydroxy Acids in High Concentration for Chemical Peeling

作　　者：田蒙 刘莉 刘善珍(综述) 王勇(审校)[1] TIAN Meng;LIU Li;LIU Shanzhen;WANG Yong(General Surgery,Peking University Third Hospital Northern Institute,Beijing 100089,China;Department of Ultrasound,Peking University Third Hospital Northern Institute,Beijing 100089,China)

机构地区：[1]北京大学第三医院北方院区综合外科,北京100089 [2]北京大学第三医院北方院区超声科,北京100089

出　　处：《中国美容医学》2023年第7期191-193,共3页Chinese Journal of Aesthetic Medicine

摘　　要：随着互联网购物、电商直播等新型美容消费模式的兴起,化学剥脱术及相关产品,尤其是高浓度果酸类产品,因其功效强、见效快成为了消费者热衷的美容消费热点。然而,由于对此类产品作用机制和临床使用方法理解不深,消费者使用不当导致“烂脸”的案例在新闻报道中屡见不鲜,同时在医患纠纷中对此类产品管理属性的明确仍不清晰。本文系统梳理果酸类产品的临床应用、作用机制、使用风险以及国内外监管政策要求,并结合国内实际探讨高浓度果酸类产品的合理监管路径,为进一步规范美容类产品的监管提供有关思路。With the rise of new beauty consumption modes,such as online shopping and e-commerce livestreaming,chemical peeling and relevant products,especially for alpha hydroxy acids(AHA)in high concentration,is becoming a hot spot for consumers.This kind of beauty products directly produces a rapid and strong physiological activity.However,the lack of understanding for their mode of action and correct operation leads to many adverse effects.This paper aims to systematically analyzing proper regulatory pathways for AHA in high concentration,on the basis of its clinical application,mode of action,potential risk,regulatory requirements at home and abroad.

关 键 词：果酸 化学剥脱术 监管路径 医学美容 风险管理 

分 类 号：R622[医药卫生—整形外科]